EP 1453541 A1 20040908 - USE OF A GLUCOKINASE ACTIVATOR IN COMBINATION WITH A GLUCAGON ANTAGONIST FOR TREATING TYPE 2 DIABETES
Title (en)
USE OF A GLUCOKINASE ACTIVATOR IN COMBINATION WITH A GLUCAGON ANTAGONIST FOR TREATING TYPE 2 DIABETES
Title (de)
VERWENDUNG EINES GLUCOKINASE AKTIVATORS IN KOMBINATION MIT EINEM GLUCAGON ANTAGONISTEN ZUR BEHANDLUNG VON DIABETES TYP 2
Title (fr)
UTILISATION D'UN ACTIVATEUR DE LA GLUCOKINASE COMBINE A UN ANTAGONISTE DU GLUCAGON POUR LE TRAITEMENT DU DIABETE DE TYPE 2
Publication
Application
Priority
- EP 02781171 A 20021203
- DK 0200814 W 20021203
- DK PA200101789 A 20011203
- DK PA200101917 A 20011219
- DK PA200101925 A 20011220
- DK PA200201006 A 20020627
- DK PA200200999 A 20020627
- DK PA200201117 A 20020718
- EP 02388015 A 20020219
- US 33687601 P 20011205
- US 34242801 P 20011220
- US 34235501 P 20011220
- US 38618501 P 20011221
- US 15168302 A 20020517
- US 39414502 P 20020703
- US 39414402 P 20020703
- US 39780902 P 20020718
Abstract (en)
[origin: WO03047626A1] The invention relates to the use of a combination of a glucokinase activator and a glucagon antagonist for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity and inhibiting the activity of glucagon is beneficial, such as for management, treatment, control, or adjunct treatment of type 1 diabetes or type 2 diabetes.
IPC 1-7
IPC 8 full level
A61K 31/16 (2006.01); A61K 31/18 (2006.01); A61K 31/195 (2006.01); A61K 31/198 (2006.01); A61K 31/405 (2006.01); A61K 31/41 (2006.01); A61K 31/415 (2006.01); A61K 31/4184 (2006.01); A61K 31/4439 (2006.01); A61K 45/06 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); A61P 43/00 (2006.01); C07D 235/08 (2006.01); C07D 235/10 (2006.01); C07D 235/12 (2006.01); C07D 235/14 (2006.01); C07D 235/18 (2006.01); C07D 403/04 (2006.01); C07D 405/04 (2006.01); C07D 409/04 (2006.01); C07D 409/06 (2006.01)
CPC (source: EP)
A61K 31/16 (2013.01); A61K 31/18 (2013.01); A61K 31/195 (2013.01); A61K 31/198 (2013.01); A61K 31/405 (2013.01); A61K 31/41 (2013.01); A61K 31/415 (2013.01); A61K 31/4184 (2013.01); A61K 31/4439 (2013.01); A61K 45/06 (2013.01); A61P 3/04 (2017.12); A61P 3/06 (2017.12); A61P 3/10 (2017.12); A61P 43/00 (2017.12); C07D 235/08 (2013.01); C07D 235/10 (2013.01); C07D 235/12 (2013.01); C07D 235/14 (2013.01); C07D 235/18 (2013.01); C07D 403/04 (2013.01); C07D 405/04 (2013.01); C07D 409/04 (2013.01); C07D 409/06 (2013.01)
Citation (search report)
See references of WO 03047626A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR
DOCDB simple family (publication)
WO 03047626 A1 20030612; AU 2002349299 A1 20030617; EP 1453541 A1 20040908; JP 2005526702 A 20050908
DOCDB simple family (application)
DK 0200814 W 20021203; AU 2002349299 A 20021203; EP 02781171 A 20021203; JP 2003548881 A 20021203